Skip to main content

Table 2 Summary of HOXA9 as targets of miRNAs in tumorigenesis and related function

From: Role of HOXA9 in solid tumors: mechanistic insights and therapeutic potential

miRNAs

Tumor type

Target

Functions

PMID

References

miR-1294

Osteosarcoma

HOXA9

miR-1294 functions as a tumor suppressor in OS progression by targeting HOXA9

30575897

[78]

miR-429

Osteosarcoma

HOXA9

miR-429 suppressed OS progression by targeting HOXA9 through Wnt/β-catenin pathway

32782562

[54]

miR-873

Osteosarcoma

HOXA9

miR-873 suppresses the development of OS by directly targeting HOXA9 and inhibiting the Wnt/β-catenin pathway

30816476

[79]

miR-652

Osteosarcoma

HOXA9

miR-652 may negatively regulate HOXA9 expression and inhibit the proliferation, migration, and invasion abilities of osteosarcoma cells through the PI3K/Akt signaling pathway

35111226

[58]

miR-641

Osteosarcoma

HOXA9

miR-641 was found to target the 3' untranslated region of homeobox protein Hox-A9 (HOXA9) and suppressed the expression of HOXA9

30838699

[81]

miR-182

Osteosarcoma

HOXA9

miR-182 downregulates Wnt/β-catenin signaling, inhibits cell proliferation, and promotes apoptosis in osteosarcoma cells by suppressing HOXA9 expression

29254169

[80]

miR-139-5p

Osteosarcoma

HOXA9

miR-139-5p depressed the invasion, proliferation, and EMT of osteosarcoma cells via targeting HOXA9

35800618

[80]

miR-638

Glioma

HOXA9

miR-638 as a tumor suppressor regulates cellular malignancy of gliomas through targeting HOXA9

30536324

[83]

miR-647

Glioma

HOXA9

HOXA9 was validated a direct target of tumor suppressor miR-647

31881106

[84]

miR-182-5p

Non-small cell lung cancer

HOXA9

MiR-182-5p may exert oncogenic influence on NSCLC through regulating target genes such as HOXA9

31906958

[85]

miR-196p

Non-small cell lung cancer

HOXA9

HOXA9 expression is inversely correlated with miR-196b levels in clinical NSCLC samples as compared to that in corresponding control samples

26586336

[41]

miR-19b-3p

Non-small cell lung cancer

HOXA9

High expression of miR-19b-3p was found to be capable of predicting poor clinical prognosis in NSCLC patients

35274735

[86]

miR-633

Colorectal adenocarcinoma

HOXA9

PCED1B-AS1 could negatively regulate the expression of HOXA9 by sponging miR-633

35176937

[87]

miR-381-3p

Human anaplastic thyroid carcinoma

HOXA9

miR-381-3p may function as a tumour suppressor to impede proliferation, migration and invasion and induce apoptosis of DOX-resistant SW1736 and CAL62 cells by inhibiting HOXA9 protein expression

34719830

[88]

miR-638

Breast cancer

HOXA9

miR-638 inhibits breast cancer progression through binding to HOXA9

34416888

[55]

miR-652

Uveal Melanoma

HOXA9

miR-652 as an oncogene promoted HIF-1alpha signaling via repression of HOXA9 in uveal melanoma cells

31740654

[46]

miR-133b

Colorectal cancer

HOXA9

miR-133b targeted the HOXA9/ZEB1 pathway to promote tumor metastasis in CRC cells

28969042

[89]

miR-139-5p

Oral squamous carcinoma

HOXA9

miR-139-5p could directly inhibit HOXA9, which might be a potential mechanism in inhibiting the proliferation, invasiveness and migration of OSCC cells

28780773

[90]